TITAN PHARMACEUTICAL INC (TTNP)
Titan Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for chronic diseases, particularly in the areas of neuroscience and addiction medicine. The company is known for its proprietary drug delivery technology and its lead product candidate, Probuphine, which is designed to provide long-term treatment for opioid dependence. Titan aims to improve patient outcomes through targeted therapies and sustained-release formulations.
Company News
Titan Pharmaceuticals' stockholders approved a business combination with Black Titan Corporation and TalenTec Sdn. Bhd., causing the stock to surge 23% in after-hours trading. The merger is still subject to additional closing conditions, including Nasdaq listing approval.
Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies undergoing mergers or sales transactions.
Use these tips for finding penny stocks in different industries in 2022 The post Which Industries Are Penny Stocks Investors Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.